Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Dry Age Related Macular Degeneration (AMD) Market’s Growth Trajectory From 2025 To 2034?
Over the past few years, the dry age related macular degeneration (amd) market has seen significant growth. The market is predicted to expand from a value of $4.49 billion in 2024 to an estimated $4.89 billion in 2025, presenting a compound annual growth rate (CAGR) of 8.8%. Factors contributing to this growth during the historical period include an increasing elderly population, a rise in chronic illness prevalence, heightened consciousness about eye health, a surge in clinical investigations centered around dry AMD, and an escalating demand for minimally invasive therapeutic methods.
In the ensuing years, the market for dry age related macular degeneration (amd) is projected to witness robust growth, expanding to$6.8 billion by 2029″ at a Compound Annual Growth Rate (CAGR) of 8.6%. Factors such as the advent of innovative therapies, an increase in healthcare expenditure, the heightened use of laser photocoagulation therapy, advancements in genetic research, and an increased emphasis on personalized medicine are expected to drive this growth during the forecast period. Notable trends for this period include advancements in diagnostic technologies, a rise in the adoption of teleophthalmology, cutting-edge treatments, approvals of products, and the launch of new products.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21176&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Dry Age Related Macular Degeneration (AMD) Market?
The surge in the elderly population is anticipated to boost the expansion of the dry age-related macular degeneration (AMD) market. The term elderly population usually refers to individuals who are 65 years old and above. The growth in this demographic is attributed to various factors like advanced medical technology, better chronic disease management, increased lifespan, and improved elderly care. With the assistance of dry age-related macular degeneration (AMD), the elderly population receives specialized treatments and management choices aiming to reduce disease progression, maintain visibility, and enhance the life quality of these older individuals affected by AMD. For example, reports released by the National Council on Aging, a US-based organization, in June 2024, indicated that in 2022, around 57.8 million adults aged 65 and above were present, making up 17.3% of the total U.S. population. This percentage had shown an upward trend from 16.9% in 2021. Consequently, the growing geriatric population is set to propel the growth of the dry age-related macular degeneration (AMD) market.
Which Primary Segments of the Dry Age Related Macular Degeneration (AMD) Market Are Driving Growth and Industry Transformations?
The dry age related macular degeneration (amd)market covered in this report is segmented –
1) By Stages: Early Age-Related Macular Degeneration; Intermediate Age-Related Macular Degeneration; Late Age-Related Macular Degeneration
2) By Age Group: Above 75 Years; Above 60 Years; Above 40 Years
3) By Route Of Administration: Oral; Injectables
4) By End Users: Hospitals And Clinics; Diagnostic Centers; Academic And Research Institutes
Subsegments:
1) By Early Age-Related Macular Degeneration: Drusen Accumulation; Retinal Pigment Epithelium Changes
2) By Intermediate Age-Related Macular Degeneration: Larger Drusen Deposits; Increased Pigmentary Abnormalities
3) By Late Age-Related Macular Degeneration: Geographic Atrophy; Central Vision Loss
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21176&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Dry Age Related Macular Degeneration (AMD) Market?# Market?
North America was the largest region in the dry age-related macular degeneration (AMD) market in 2024. The regions covered in the dry age related macular degeneration (AMD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Dry Age Related Macular Degeneration (AMD) Market?
Key players in the dry age related macular degeneration (AMD) industry are gearing up to introduce new, innovative technologies and therapies such as light delivery systems. These systems, aimed at activating and targeting retinal cells, may hinder the progress of the disease. Light delivery systems are a form of technology developed to channel light with therapeutic purposes, especially with regards to medical treatments. Take for instance, LumiThera Inc., a US medical device firm. In January 2024, they introduced photobiomodulation (PBM) for dry age-related macular degeneration (AMD) through the Valeda Light Delivery System. This solution, the first of its kind with FDA approval, targets vision loss in dry AMD patients who presently have few treatment choices. To gather data on long-term patient outcomes following treatment with the Valeda system, LumiThera launched the EUROLIGHT registry study. The Valeda system makes use of a multi-wavelength light delivery approach featuring three specific wavelengths (590 nm, 660 nm, and 850 nm). This non-invasive procedure can be carried out with either an open or shut eyelid and generally necessitates nine sessions spanning three to four weeks.
View the full report here:
What Parameters Are Used to Define the Dry Age Related Macular Degeneration (AMD) Market?
Dry age related macular degeneration (AMD) refers to a progressive eye condition characterized by the gradual deterioration of the macula, the central part of the retina, leading to blurred central vision. They are used for managing and slowing the progression of the disease through treatments like vitamins, nutritional supplements, and emerging pharmaceutical therapies.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21176
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model